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Abstract: The aim of this study was to examine the potential correlation of sleep characteristics 
with glucose metabolism in nondiabetic men with obstructive sleep apnea syndrome (OSAS). 
Included were 31 male patients (mean age 46.7 ± 11 years), recently diagnosed with OSAS by 
full polysomnography. There was a significant correlation of fasting glucose and glycosylated 
hemoglobin (HbA1c) levels with arousal index (P = 0.047 and P = 0.014, respectively). Moreover, 
HbA1c levels were correlated with apnea hypopnea index (P = 0.009), a widely accepted marker 
of the severity of OSAS, and with percentage of sleep time with saturation of hemoglobin with 
oxygen as measured by pulse oximetry (SpO2) 90% (t  90%) (P = 0.010). Finally, glucose 
and HbA1c levels showed a significant negative correlation with average SpO2 (P = 0.013 and 
P = 0.012, respectively) and, additionally, glucose levels with minimum SpO2 (P = 0.027) during 
sleep. In conclusion, severity of OSAS among nondiabetic men is associated with increased 
HbA1c levels and increased fasting glucose. Thus, severity of OSAS may be an additional marker 
of cardiovascular risk, as well as of future diabetes, in these subjects. However, further work is 
needed to confirm the clinical significance of these observations.
Keywords: obstructive sleep apnea syndrome, glucose metabolism, glycated hemoglobin, 
sleep disordered breathing
Introduction
Obstructive sleep apnea syndrome (OSAS), a common disorder, affecting 
approximately 3%–7% of adult men and 2%–5% of adult women in the general 
population,1 is being increasingly recognized as an important cause of morbidity and 
mortality.2 This clinical condition is characterized by repeated episodes of complete 
or partial obstruction of the upper airway during sleep, associated with increased 
respiratory efforts, intermittent arterial oxygen desaturation, systemic and pulmonary 
arterial blood pressure alterations and sleep fragmentation. The cardinal symptoms 
of OSAS are nocturnal respiratory pauses, interrupted by loud snoring, and excessive 
daytime sleepiness.2
OSAS and type 2 diabetes mellitus (DM) are common comorbid conditions. Indeed, 
the prevalence of OSAS is estimated to be between 18% and 36% in subjects with 
type 2 DM.3,4 Vice versa, the prevalence of type 2 DM is approximately 30% in OSAS 
patients.5 Several lines of evidence suggest an independent association of OSAS with 
insulin resistance and DM.6–9
Ip and colleagues reported that markers of OSAS severity (Apnea Hypopnea Index 
[AHI] and minimum oxygen saturation) were associated with insulin resistance,6 
while Punjabi and colleagues found that sleep-disordered breathing (SDB) was Vascular Health and Risk Management 2009:5 752
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associated with insulin resistance in mildly obese but 
otherwise healthy males from the general population.7 
Cross-sectional data from the Sleep Heart Health Study 
and the Wisconsin Sleep Cohort found similar results 
in population cohorts.8,9 However, the longitudinal data 
from the Wisconsin Cohort could not demonstrate a clear 
relationship between SDB and the subsequent develop-
ment of DM.9 Other studies in snorers have confirmed the 
association of SDB and insulin resistance or diabetes in 
nonobese Korean and Indian males,10,11 and similar results 
were found in subjects with suspected OSAS.5,12,13 In all 
reports, the association was independent of obesity, even 
though obesity is known to increase the risk for impaired 
glucose tolerance. In normal subjects, hypoxia appears to 
be an important contributor to glucose intolerance.14 Recent 
state-of-the art reviews have emphasized the need for fur-
ther clinical research in this direction.15,16
Little is known so far on the association between glycemic 
profile and severity of OSAS in patients that do not meet the 
criteria for the diagnosis of diabetes. Thus, the aim of the 
present study was to examine the potential correlation of 
sleep characteristics with glucose metabolism in nondiabetic 
men with OSAS.
Materials and methods
Study group
Thirty one consecutive male patients, with recently diagnosed 
OSAS (AHI  15/hour) by polysomnography between 
January and June 2009, comprised the study group. Each 
participant was evaluated by full clinical examination and 
completed a detailed questionnaire about sleep habits. 
Exclusion criteria were: known diabetes mellitus or fast-
ing glycemia (fasting glucose 126 mg/dl or glycosylated 
hemoglobin [HbA1c]  6.5%),17 current smoking, cardio-
vascular or cerebrovascular disease, hypertension or other 
chronic disease, systemic medication use, as well as previous 
diagnosis/treatment for OSAS. The study was approved by the 
Institutional Ethics Committee and all subjects gave written 
informed consent.
Polysomnography
Each subject underwent standard full night polysomnography 
(PSG). Sleep records were manually scored, according to 
standardized criteria.18 AHI was defined as the total number 
of apneas and hypopneas per hour of electroencephalographic 
sleep. Arousal Index (AI) was the total number of arousals 
per hour of recorded sleep. OSAS was defined as an AHI 
of  15/hour.
Blood assays
Fasting venous blood samples were collected the day after 
PSG, between 8 and 9 AM, after an overnight fast. Bio-
chemical analyses were performed in an ILAB 600 analyzer 
(Biochem, Tokyo, Japan) with enzymatic method for glucose 
(mg/dL) while HbA1c was measured by high-performance 
liquid chromatography (Adams A1c HA-8160; Arkray, 
Kyoto, Japan).
Statistical analysis
Analysis was performed with SPSS for Windows, version 
15.0 (SPSS, Chicago, IL, USA). Normality was examined 
by the Kolmogorov-Smirnoff test. Descriptive results for 
continuous variables are expressed as mean ± SD. Regres-
sion analysis was applied to explore relationships between 
glucose or HbA1c values and apnea-related characteristics, 
independently of body mass index (BMI). Statistical signifi-
cance was defined at a level of 5% (P  0.05).
Results
Mean age was 46.7 ± 11 years (ranging between 28–71 years) 
and mean BMI was 34.8 ± 6.6 kg/m2 (ranging between 28 and 
54.9 Kg/m2). Neck circumference was 44.5 ± 2.8 cm while 
waist circumference was 119.9 ± 18.6 cm. Sleep and meta-
bolic characteristics of patients are presented in Table 1.
A significant correlation between HbA1c levels and 
apnea-related parameters (AHI, average saturation of hemo-
globin with oxygen as measured by pulse oximetry [SpO2], 
Table 1 Sleep and metabolic characteristics of OSAS patients
Parameter Mean ± SD Range
AHI (events/hour) 55.1 ± 26.4 15.2–108
Average SpO2 (%) 90 ± 5.7 72–95
Minimum SpO2 (%) 71.7 ± 12.1 41–88
t  90 (%) 31.39 ± 31.42 0–99
AI (events/hour) 45.1 ± 23.3 5–100
Sleep efficiency (%TST) 77.4 ± 14.4 34.4–93.9
Sleep latency (minutes) 23.7 ± 15.1 5.5–66.5
Stage 1 (%TST) 36.7 ± 16.4 9.4–77.1
Stage 2 (%TST) 45.7 ± 10.4 25.8–69.1
SWS (%TST) 8 ± 9.3 0–38.2
REM (%TST) 12.4 ± 5.8 0–24.4
Fasting glucose (mg/dl) 95.1 ± 12.5 67–125
HbA1c (%) 5.2 ± 0.6 4.2–6.3
Abbreviations:   AHI,   Apnea Hypopnea Index;   AI,   Arousal Index; HbA1c, glycosylated 
hemoglobin; OSAS, obstructive sleep apnea syndrome; REM, rapid eye motion; 
SD, standard deviation; SpO2, saturation of hemoglobin with oxygen as measured by 
pulse oximetry; SWS, slow-wave sleep;   TST, total sleep time.Vascular Health and Risk Management 2009:5 753
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percentage of sleep time with SpO2 90%, ie, t  90, 
and  AI) was revealed (Figure 1). Moreover, fasting glucose 
levels were significantly correlated with AI and average and 
minimum SpO2 (Figure 2). As shown in Table 2, correlations 
were independent of BMI.
Discussion
The present study examined the potential correlation of 
sleep characteristics with glucose metabolism in nondiabetic 
men with OSAS. Our results suggest that in nondiabetic 
male OSAS patients without comorbidities, the severity 
of OSAS (evaluated by the number of respiratory cessa-
tion events, the indices of hypoxemia during sleep and the 
arousal index) is associated with increased fasting glucose 
and HbA1c levels.
The novel association of HbA1c with severity of OSAS 
appears interesting, and may have important implica-
tions in clinical practice. Essentially, not only is HbA1c 
the major target for the prevention of complications in 
type 2 DM,19 but it also represents a significant risk marker 
for cardiovascular disease in the general population.20–22 
It is, therefore, tempting to consider whether the severity of 
OSAS may be viewed as a risk marker for cardiovascular 
disease. This assumption enhances the increasing aware-
ness that OSAS itself is a risk factor for cardiovascular 
morbidity.23 Equally importantly, HbA1c is being increas-
ingly appreciated as a risk marker for the development 
of DM in the general population.24,25 Hence, the severity 
of OSAS may be associated with increased risk for the 
development of DM. The utility of HbA1c in the prediction 
of diabetes in subjects with OSAS is plausible, given the 
association between these two conditions. However, the 
number of our patients is small, and further research is 
required to confirm our findings.
Similarly, a significant correlation was observed between 
fasting glucose levels and severity of nocturnal hypoxemia 
(evaluated by the average SpO2 and the minimum SpO2 dur-
ing sleep). In view of the fact that the level of hyperglycemia 
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Figure 1 Correlations of HbA1c levels with AHI (A),  AI (B), average SpO2 (C), and percentage of sleep time with SpO2  90% (D).
Abbreviations:  AHI, Apnea Hypopnea Index;    AI,    Arousal Index; HbA1c, glycosylated hemoglobin; SpO2, saturation of hemoglobin with oxygen as measured by pulse oximetry.Vascular Health and Risk Management 2009:5 754
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is an established risk factor for both diabetes20,25 and 
cardiovascular morbidity and mortality,20,26–28 this association 
enhances the significance of the severity of OSAS as a risk 
factor for diabetes and vascular disease. While it is known 
that OSAS and impaired glucose homeostasis are inter-
related,6–11 our dataset emphasizes the role of OSAS severity 
in putting otherwise healthy male patients at increased car-
diovascular risk.
Both fasting glucose and HbA1c exhibited a significant 
correlation with AI. This finding indicates that the effect 
of OSAS on glycemic profile was, partly at least, mediated 
by sympathetic nervous system activation.1,5 The latter is 
a recognized mechanism underlying the pathogenesis of 
insulin resistance and impaired glucose metabolism in OSAS 
patients.2,5–8 Our data provide additional evidence for the 
potential role of sympathetic overactivity in the modifica-
tion of hyperglycemia in otherwise healthy individuals with 
OSAS.
Finally, BMI did not correlate with HbA1c levels or glu-
cose levels. Hence, OSAS severity was directly associated 
Table 2 Results of regression analysis
Glucose levels
B ± SD Beta P
BMI 0.640 ± 0.336 0.339 0.223
AHI 0.092 ± 0.095 0.195 0.340
AI 0.196 ± 0.094 0.365 0.047
t  90 12.405 ± 7.176 0.312 0.095
Average SpO2 -0.973 ± 0.366 -0.442 0.013
Minimum SpO2 -0.419 ± 0.179 -0.410 0.027
HbA1c levels
BMI 0.000 ± 0.016 0.006 0.976
AHI 0.011 ± 0.004 0.511 0.009
AI 0.011 ± 0.004 0.448 0.014
t  90 0.877 ± 0.319 0.470 0.010
Average SpO2 -0.470 ± 0.017 -0.456 0.012
Minimum SpO2 -0.015 ± 0.09 -0.305 0.112
Abbreviations:   AHI,   Apnea Hypopnea Index;   AI,   Arousal Index; BMI, body mass 
index; SD, standard deviation; SpO2, saturation of hemoglobin with oxygen as 
measured by pulse oximetry.
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Figure 2 Correlations of fasting glucose levels with AHI (A),    AI (B), average SpO2 (C), and minimum SpO2 (D).
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with impaired glucose metabolism independently of obesity. 
This result agrees with studies showing that SDB is associated 
with glucose intolerance and insulin resistance independently 
of BMI.8,9,12,13 The role of SDB is enhanced by evidence 
showing that experimental hypoxia directly causes glucose 
intolerance.14 However, other workers advocate an important 
role for central obesity in impaired glucose metabolism, 
and so recent state-of-the art reviews highlight the need 
for further clarification.15,16 In the type of subjects herein 
examined, OSAS severity appears to outweigh obesity, as 
demonstrated by its direct association with impaired glucose 
metabolism.
Notably, this study excluded women, in order to avoid 
potential discrepancies between the two genders. Indeed, 
there is evidence of a different effect of sleep apnea on 
metabolic profile and on inflammatory response in women, 
partly at least due to different hormonal regulation.1,29 For 
this reason, the correlations found need to be investigated 
in women as well.
The limitations of the present report include the small 
number of patients and the cross-sectional design. Based on 
our findings, it is plausible to propose that risk factors for 
diabetes and vascular disease in otherwise healthy OSAS 
patients may be identified in association with OSAS severity. 
Nonetheless, there is no prospective data to confirm that this 
risk translates into worse outcome in actual clinical practice. 
Such follow-up was beyond the scope of this study, and 
further prospective research is needed to provide a definite 
answer.
In conclusion, among nondiabetic men with OSAS, the 
severity of this condition is associated with increased HbA1c 
levels and increased fasting glucose. Thus, the severity of 
OSAS may be an additional marker of cardiovascular risk 
as well as of future diabetes in these subjects. Nevertheless, 
the clinical significance of our observations remains to be 
confirmed by prospective studies.
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